Pharmaceutical

Magazine: Lula’s progress plan for Brazil: a year on

In this issue: Lula's progress plan for Brazil, tracking opioid lawsuit settlements in the US, the cell & gene therapy landscape in the US, the latest on ESG in pharma, and more.

May 25, 2024 - 04:00
Magazine: Lula’s progress plan for Brazil: a year on
In this issue: Lula's progress plan for Brazil, tracking opioid lawsuit settlements in the US, the cell & gene therapy landscape in the US, the latest on ESG in pharma, and more.
Read the original article

Tags:

Previous Article

Biocon and Handok link to commercialise Liraglutide in South Korea

Next Article

Risk of Low Blood Sugar Identified in Novo Nordisk’s Once-Weekly Insulin Before ...

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

STAT+: Pharmalittle: A not-so-new Biogen?; ALS Association and 15 chapters part ways over organizational clashes

STAT+: Pharmalittle: A not-so-new Biogen?; ALS Associat...

Jun 14, 2023

STAT+: Biogen says it will cut costs by $700 million, slash 1,000 jobs

STAT+: Biogen says it will cut costs by $700 million, s...

Jul 26, 2023

STAT+: J&J agrees not to enforce patents on a key tuberculosis drug in dozens of poor countries

STAT+: J&J agrees not to enforce patents on a key tuber...

Sep 30, 2023